NCT02737475 2022-01-25An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have SpreadBristol-Myers SquibbPhase 1/2 Completed166 enrolled 57 charts